Inclisiran versus alirocumab in improving lipid profile parameters: a systematic review and meta-analysis
Saad Cleto A, Schirlo JM, Oliveira Gomes VH, et al.
Diabetes Obes Metab. Pub. online 25 Nov 2024.
Leggi
National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990-2021, and forecasts up to 2050
Ng M, Dai X, Cogen RM et al. GBD 2021 US Obesity Forecasting Collaborators
Lancet. 2024:S0140-6736(24)01548-4.
Leggi
Survodutide, a glucagon receptor/glucagon-like peptide-1 receptor dual agonist, improves blood pressure in adults with obesity: a post hoc analysis from a randomized, placebo-controlled, dose-finding, phase 2 trial
le Roux CW, Steen O, Lucas KJ, et al.
Diabetes Obes Metab. Pub. online 25 Nov 2024.
Leggi
SGLT2 inhibitors, cardiovascular outcomes, and mortality across the spectrum of kidney disease: A systematic review and meta-analysis
Spiazzi BF, Piccoli GF, Wayerbacher LF, et al.
Diabetes Res Clin Pract. 2024:111933.
Leggi
Time to development of macrovascular complications and its predictors among type 2 diabetes mellitus patients at Jimma University Medical Center
Adare AF, Tiyare FT, Marine BT
BMC Endocr Disord. 2024;24(1):252.
Leggi
Clinical utility of novel diabetes subgroups in predicting vascular complications and mortality: up to 25 years of follow-up of the HUNT study
Bjarkø VV, Haug EB, Langhammer A, et al.
BMJ Open Diabetes Res Care. 2024;12(6):e004493.
Leggi
Hypoglycemic events may trigger acute ischemic stroke within 30 days in those with diabetes: a case-crossover study
Makam S, Stein LK, Dhamoon MS
Stroke. Pub. online 22 Nov 2024.
Leggi
NUOVA FAD: IL PUNTO SULLA GESTIONE DEL PAZIENTE CON DT2
23 DICEMBRE 2024 – 23 GIUGNO 2025
Leggi
